Lymphocyte-mediated immunosurveillance of epithelial cancers?

[1]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[2]  F. Abdul-Karim,et al.  Systemic deficits in transporter for antigen presentation (TAP)‐1 or proteasome subunit LMP2 have little or no effect on tumor incidence , 2001, International journal of cancer.

[3]  M. Smyth,et al.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. , 2001, Blood.

[4]  J. Trapani,et al.  Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma , 2000, The Journal of experimental medicine.

[5]  I. Svane,et al.  CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3‐methylcholanthrene , 2000, Clinical and experimental immunology.

[6]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. , 2000, Seminars in oncology.

[7]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[9]  P S Gartside,et al.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. , 1999, Cancer research.

[10]  H. Heslop,et al.  Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation. , 1999, Current opinion in oncology.

[11]  P. Coulie,et al.  Antitumor immunity at work in a melanoma patient. , 1999, Advances in cancer research.

[12]  Piero Musiani,et al.  Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice , 1998, The Journal of experimental medicine.

[13]  D. Schendel,et al.  Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo. , 1998, Cancer research.

[14]  R. Schreiber,et al.  Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .

[15]  R. Tampé,et al.  Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell‐mediated immune recognition of human melanoma cells , 1998, International journal of cancer.

[16]  J. Lokich.  Spontaneous regression of metastatic renal cancer. Case report and literature review. , 1997, American journal of clinical oncology.

[17]  I. Svane,et al.  MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice , 1997, Scandinavian journal of immunology.

[18]  K. McClain.  Immunodeficiency states and related malignancies. , 1997, Cancer treatment and research.

[19]  R. Zinkernagel,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[20]  J. Bryant,et al.  Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. , 1996, The Journal of clinical investigation.

[21]  H. Ljunggren,et al.  Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice , 1996, European journal of immunology.

[22]  J. Roder,et al.  Spontaneous and induced primary oncogenesis in natural killer (nk)‐cell‐deficient beige mutant mice , 1985, International journal of cancer.

[23]  R. Gatti,et al.  Occurrence of malignancy in immunodeficiency diseases: A literature review , 1971, Cancer.